drugset / Trial / NCT01046799
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir
Phase 3
Completed
20 enrolled
HepNet Study House, German Liverfoundation
Hannover Medical School · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether hepatitis B immunoglobin can be discontinued early after hepatitis B virus (HBV) induced liver transplantation and be replaced by the nucleoside analogue entecavir to prevent hepatitis B reinfection.
Timeline
- Start
- 2008-03
- Primary completion
- 2014-06
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | — | — |